Importantly, despite individuals with predominantly mild-moderate COPD within the investigated population, abnormal cardiac biomarkers were common; every fourth individual had hs-cTnI ≥5 ng/L, and almost one in 10 had both elevated hs-cTnI and ischemic ECG abnormalities. This evidence concerns the gene TNNI3 and chronic obstructive pulmonary disease.